Skip to content
healthcare.dev

Acetazolamide

NDC 69367-209, Acetazolamide, capsule, extended release, from Westminster Pharmaceuticals, LLC.

Product NDC
69367-209
Status
Listed
Labeler
Westminster Pharmaceuticals, LLC
Dosage form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA090779
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69367-209 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ACETAZOLAMIDE500 mg/1

Pharmacologic classes

Carbonic Anhydrase Inhibitor [EPC]; Carbonic Anhydrase Inhibitors [MoA]; Sulfonamides [CS]

Package NDCNDC-11Package
69367-209-0169367020901100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (69367-209-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/417b1df2-63bc-473c-9e02-5f93dd45554d
  • NADAC price for package 69367020901

    GET /v1/drugs/nadac/69367020901

Use it

Look up 69367-209 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69367-209 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69367-209. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.